ArticleACS omega2022
Multifunctional MXene/Aramid Nanofiber Composite Films for Efficient Electromagnetic Interference Shielding and Repeatable Early Fire Detection.
Article in ACS omega, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Recent Advances in MXene-Based Composites for Their Efficiency in the Degradation of Antibiotics and Water Splitting.Molecules (Basel, Switzerland) · 2025Review
- Progress in Surface and Interface Modification Strategies of MXene Materials for Energy Storage Applications.Materials (Basel, Switzerland) · 2025Review
- Review of MXene synthesis and applications in electromagnetic shielding.RSC advances · 2025Review
- Nacre-like Anisotropic Multifunctional Aramid Nanofiber Composites for Electromagnetic Interference Shielding, Thermal Management, and Strain Sensing.Molecules (Basel, Switzerland) · 2024Article
- Ultrafast Response and Threshold Adjustable Intelligent Thermoelectric Systems for Next-Generation Self-Powered Remote IoT Fire Warning.Nano-micro letters · 2024Article
- Two-Dimensional MXenes: Innovative Materials for Efficient Thermal Management and Safety Solutions.Research (Washington, D.C.) · 2024Review
- Rapid Fabrication of Flexible Cu@Ag Flake/SAE Composites with Exceptional EMIS and Joule Heating Performance.ACS omega · 2023Article
- Progress and challenges of emerging MXene based materials for thermoelectric applications.iScience · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Rapid development of highly integrated electronic and telecommunication devices has led to urgent demands for electromagnetic interference (EMI) shielding materials that incorporate flame retardancy, and more desirably the early fire detection ability, due to the potential fire hazards caused by heat propagation and thermal failure of the devices during operation. Here, multifunctional flexible films having the main dual functions of high EMI shielding performance and repeatable fire detection ability are fabricated by vacuum filtration of the mixture of MXene and aramid nanofiber (ANF) suspensions. ANFs serve to reinforce MXene films via the formation of hydrogen bonding between the carbonyl groups of ANFs and the hydroxyl groups of MXene. When the ANF content is 20 wt %, the tensile strength of the film is increased from 24.6 MPa for a pure MXene film to 79.5 MPa, and such a composite film (9 μm thickness) exhibits a high EMI shielding effectiveness (SE) value of ∼40 dB and a specific SE (SSE) value of 4361.1 dB/mm. Upon fire exposure, the composite films can trigger the fire detection system within 10 s owing to the thermoelectric property of MXene. The self-extinguishing feature of ANFs ensures the structural integrity of the films during burning, thus allowing for continuous alarm signals. Moreover, the films also exhibit excellent Joule heating and photothermal conversion performances with rapid response and sufficient heating reliability.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.